Diversity-Oriented Synthesis as a Strategy for Fragment Evolution against GSK3β.
ACS Med Chem Lett
Authors | |
Abstract | Traditional fragment-based drug discovery (FBDD) relies heavily on structural analysis of the hits bound to their targets. Herein, we present a complementary approach based on diversity-oriented synthesis (DOS). A DOS-based fragment collection was able to produce initial hit compounds against the target GSK3β, allow the systematic synthesis of related fragment analogues to explore fragment-level structure-activity relationship, and finally lead to the synthesis of a more potent compound. |
Year of Publication | 2016
|
Journal | ACS Med Chem Lett
|
Volume | 7
|
Issue | 9
|
Pages | 852-6
|
Date Published | 2016 Sep 08
|
DOI | 10.1021/acsmedchemlett.6b00230
|
PubMed ID | 27660690
|
PubMed Central ID | PMC5018862
|
Links | |
Grant list | P30 DK020541 / DK / NIDDK NIH HHS / United States
T32 GM007288 / GM / NIGMS NIH HHS / United States
|